Pradaxa Sales Data

Rank 88 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Pradaxa U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 88 (4) -0.53% -3.53%
Q3 2013 84 (11) -2.91% -11.19%
Q2 2013 73 (2) -3.34% -2.75%
Q1 2013 75 (4) 4.76% -0.20%
Q4 2012 79 (4) -1.83% -4.18%
Q3 2012 75 (1) 3.84% 4.58%
Q2 2012 76 (5) 0.13% -2.77%
Q1 2012 81 (4) 5.13% 6.53%
Q4 2011 85 (7) 16.27% 16.30%
Q3 2011 92 ()

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
July 23, 2014Boehringer Ingelheim: Benefits and Safety of Pradaxa Repeatedly Confirmed
November 18, 2013Antidote Might Reverse Complication From Blood Thinner Pradaxa
November 8, 2012Boehringer Recalls Manufacturing Lot of Pradaxa
May 25, 2012European Medicines Agency Updates Patient and Prescriber Information for Pradaxa
December 8, 2011FDA Drug Safety Communication: Safety review of post-market reports of serious bleeding events with the anticoagulant Pradaxa (dabigatran etexilate mesylate)
July 21, 2011Pradaxa (dabigatran etexilate mesylate) Capsules Now on Formulary at Nation's Top Heart Hospitals
November 8, 2010New Drug, Pradaxa, May Prevent Second Stroke in Certain Heart Patients
October 20, 2010Pradaxa Approved to Fight Dangerous Irregular Heartbeat, Stroke
October 20, 2010Pradaxa Approved for Atrial Fibrillation
February 26, 2010Current Blood Thinners Face Tough Competition
December 7, 2009New Blood Thinner Could Replace Warfarin to Fight Venous Clots
November 18, 2009Newer Blood Thinners May Outperform Old Standbys
November 15, 2009Alternative to Warfarin May Cut Risk of Bleeding
August 30, 2009New Anti-Clotting Drug Beats Plavix
Hide
(web5)